CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$1.29 USD
-0.07 (-4.81%)
Updated Jul 15, 2024 03:58 PM ET
After-Market: $1.29 +0.01 (0.39%) 7:40 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.29 USD
-0.07 (-4.81%)
Updated Jul 15, 2024 03:58 PM ET
After-Market: $1.29 +0.01 (0.39%) 7:40 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Zacks News
Rising Coronavirus Cases Spark Lockdown Fears: 5 Defensive Picks
by Zacks Equity Research
Given the current coronavirus scenario, investors can invest in defensive stocks that can return well even during phases of market volatility
3 Inexpensive MedTech Gainers of 2H20 Beyond TMO and RMD
by Zacks Equity Research
Here we look at three cheap MedTech stocks that investors can take a look at apart from giants like Thermo Fisher and ResMed that are expensive.
CoDiagnostics, Inc. (CODX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) closed at $18.19 in the latest trading session, marking a +1% move from the prior day.
Is CoDiagnostics (CODX) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
CoDiagnostics, Inc. (CODX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) closed the most recent trading day at $19.46, moving +0.57% from the previous trading session.
CoDiagnostics, Inc. (CODX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CoDiagnostics, Inc. (CODX) closed at $18.23, marking a +0.05% move from the previous day.
Has CoDiagnostics (CODX) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Harrow Health (HROW) in Focus: Stock Moves 6.9% Higher
by Zacks Equity Research
Harrow Health (HROW) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
The Zacks Analyst Blog Highlights: RCI Hospitality, Great Lakes Dredge & Dock, CoDiagnostics, Sportsman's Warehouse and Resources Connection
by Zacks Equity Research
The Zacks Analyst Blog Highlights: RCI Hospitality, Great Lakes Dredge & Dock, CoDiagnostics, Sportsman's Warehouse and Resources Connection
Has CoDiagnostics (CODX) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Here's How to Play May's Stunning Jobs Report
by Tirthankar Chakraborty
A mind-boggling 2.5 million were employed in May, in contrast to several economists' apprehensions of a loss of 7.25 million jobs. Here's how to play May's surprising jobs gain -
Top Ranked Momentum Stocks to Buy for June 5th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 5th.
Find Strong Buy Stocks for the Coronavirus Market Rally with this Screener
by Benjamin Rains
Zacks Rank #1 (Strong Buy) stocks outperform the market in both good and bad times. However, there are over 200 stocks that earn a Zacks Rank #1 at any given time...
5 Stocks to Bank on May's Strong Market Rally
by Zacks Equity Research
Stocks made a comeback in May, as major indexes marched higher on the economy gathering steam, government's stimulus measures and optimism over a potential vaccine for coronavirus.
Top Ranked Momentum Stocks to Buy for May 27th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 27th
Co-Diagnostics (CODX): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Co-Diagnostics (CODX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Co-Diagnostics' Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Co-Diagnostics.
Can CoDiagnostics, Inc. (CODX) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CoDiagnostics, Inc. (CODX) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is CoDiagnostics (CODX) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Are Options Traders Betting on a Big Move in Co-Diagnostics (CODX) Stock?
by Zacks Equity Research
Investors need to pay close attention to Co-Diagnostics (CODX) stock based on the movements in the options market lately.
CoDiagnostics, Inc. (CODX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -25.00% and 40.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
CoDiagnostics Inc (CODX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CoDiagnostics Inc (CODX) closed at $17.11 in the latest trading session, marking a +0.38% move from the prior day.
Is Co-Diagnostics (CODX) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Company News for Apr 21, 2020
by Zacks Equity Research
Companies In The News Are: CYCC, CODX, NBY, EXEL